CAR-T Clinical Trials in Berlin
2 recruitingBerlin, Germany
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies
Leukemia RelapseLymphoma Diffuse Large B-cellLeukemia and Lymphoma+1 more
AvenCell Therapeutics, Inc.178 enrolled13 locationsNCT07284433
Recruiting
Phase 3
CAR-T Long Term Follow Up (LTFU) Study
Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program
Novartis Pharmaceuticals1,400 enrolled118 locationsNCT02445222